![Christian Schneider](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christian Schneider
Directeur Général chez
Schneider Schreibgeräte Gmbh
Profil
Dr. Christian Schneider is a Managing Partner at Vesalius Biocapital Partners SARL, a Co-Managing Director at Schneider Schreibgeräte Gmbh and a Principal at Vectura GmbH.
He is on the Board of Directors at Trod Medical NV and Ventaleon GmbH.
Dr. Schneider was previously employed as a Managing Partner by PolyTechnos Venture-Partners II GmbH, a Manager-External Research by Centocor, Inc., a Principal by Roche Diagnostics GmbH, an Independent Director by Advitos GmbH, a Director-Executive Board by AplaGen GmbH, and an Independent Director by MagnaMedics GmbH.
He also served on the board at deVGen NV, Humedics GmbH, OncoMethylome Sciences SA and Shire Orphan Therapies GmbH.
He received his MBA from Penn State Great Valley and a doctorate degree from Ludwig-Maximilians-Universität München.
Postes actifs de Christian Schneider
| Sociétés | Poste | Début |
|---|---|---|
Vesalius Biocapital Partners SARL
 Vesalius Biocapital Partners SARL Investment ManagersFinance Vesalius Biocapital Partners invests in companies located in Europe. The firm targets companies operating in the fields of life science, therapeutics, medical devices and diagnostics sectors. It provides financing for seed, early and later stage capital requirements with an investment size of up to USD 10 million. It acts as a lead & co-investor and acquires majority interest and also takes a seat on the board of directors. | Private Equity Investor | 01/01/2008 |
Schneider Schreibgeräte Gmbh
 Schneider Schreibgeräte Gmbh Industrial ConglomeratesProducer Manufacturing Engages in manufacturing of products | Directeur Général | - |
Trod Medical NV
 Trod Medical NV Medical SpecialtiesHealth Technology Develops and commercializes tools for use in the focal ablation of soft tissues | Directeur/Membre du Conseil | - |
Anciens postes connus de Christian Schneider
| Sociétés | Poste | Fin |
|---|---|---|
| MDXHEALTH SA | Directeur/Membre du Conseil | 23/01/2009 |
PolyTechnos Venture-Partners GmbH
 PolyTechnos Venture-Partners GmbH Investment ManagersFinance PTVP originally focused on early-stage investing in advanced technology sectors, then evolved towards later-stage investments. Their portfolio companies are typically European high-growth companies where they identified a special situation likely to create significant value within a short period of time, a unique business model, limited technology risk, limited burn rate, and an identified value inflection point for a global trade sale or an IPO. PTVP's focus is on German-speaking countries. They provide hands-on support to promote the global development of their investee companies. Their portfolio is invested in sectors including software, information technology, life sciences, energy and clean technology, as well as in companies born of the convergence of these fields. | Private Equity Investor | 05/11/2007 |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Manufactures healthcare products | Corporate Officer/Principal | - |
Roche Diagnostics GmbH
 Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Develops innovative medicines, treatments and diagnostics | Corporate Officer/Principal | - |
MagnaMedics GmbH
 MagnaMedics GmbH Medical SpecialtiesHealth Technology Develops and markets biological diagnostic products | Directeur/Membre du Conseil | - |
Formation de Christian Schneider
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
90
Relations au 1er degré
17
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Manufactures healthcare products | Health Technology |
MDxHealth SA
 MDxHealth SA Medical SpecialtiesHealth Technology Develops and commercializes epigenetic tests & services for cancer assessment | Health Technology |
Shire Orphan Therapies GmbH
 Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Develops novel drugs | Health Technology |
Roche Diagnostics GmbH
Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Develops innovative medicines, treatments and diagnostics | Commercial Services |
deVGen NV
 deVGen NV BiotechnologyHealth Technology Provides biotechnology services for the pharmaceutical and agrochemical industries | Health Technology |
Ludwig-Maximilians-Universität München
 Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trod Medical NV
Trod Medical NV Medical SpecialtiesHealth Technology Develops and commercializes tools for use in the focal ablation of soft tissues | Health Technology |
MagnaMedics GmbH
MagnaMedics GmbH Medical SpecialtiesHealth Technology Develops and markets biological diagnostic products | Health Technology |
Vesalius Biocapital Partners SARL
Vesalius Biocapital Partners SARL Investment ManagersFinance Vesalius Biocapital Partners invests in companies located in Europe. The firm targets companies operating in the fields of life science, therapeutics, medical devices and diagnostics sectors. It provides financing for seed, early and later stage capital requirements with an investment size of up to USD 10 million. It acts as a lead & co-investor and acquires majority interest and also takes a seat on the board of directors. | Finance |
AplaGen GmbH
 AplaGen GmbH BiotechnologyHealth Technology Develops and markets therapeutic peptides | Health Technology |
Vectura GmbH
 Vectura GmbH Miscellaneous Commercial ServicesCommercial Services Develops and manufactures aerosol inhalation systems | Commercial Services |
PolyTechnos Venture-Partners GmbH
PolyTechnos Venture-Partners GmbH Investment ManagersFinance PTVP originally focused on early-stage investing in advanced technology sectors, then evolved towards later-stage investments. Their portfolio companies are typically European high-growth companies where they identified a special situation likely to create significant value within a short period of time, a unique business model, limited technology risk, limited burn rate, and an identified value inflection point for a global trade sale or an IPO. PTVP's focus is on German-speaking countries. They provide hands-on support to promote the global development of their investee companies. Their portfolio is invested in sectors including software, information technology, life sciences, energy and clean technology, as well as in companies born of the convergence of these fields. | Finance |
Advitos GmbH
 Advitos GmbH Medical SpecialtiesHealth Technology Develops and commercializes liver support therapy devices | Health Technology |
Schneider Schreibgeräte Gmbh
Schneider Schreibgeräte Gmbh Industrial ConglomeratesProducer Manufacturing Engages in manufacturing of products | Producer Manufacturing |
Humedics GmbH
 Humedics GmbH Packaged SoftwareTechnology Services Develops diagnostic systems technology for assessment of liver diseases | Technology Services |
Ventaleon GmbH
 Ventaleon GmbH Pharmaceuticals: OtherHealth Technology Engages in the research, development, manufacture, and distribution of antiviral substances and treatments taken by inhalation | Health Technology |
Penn State Great Valley
 Penn State Great Valley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
